Skip to content

Clinical trials

Phase 2 Urogenital Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Diseases Phase: Phase 2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20161
20171
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Emory University2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Antev Ltd.1
Jade Biosciences, Inc.1
M.D. Anderson Cancer Center1
National Center for Research Resources (NCRR)1
The Netherlands Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Diseases9
Neoplasms3
Rare Diseases3
Glomerulonephritis, IGA2
Prostatic Neoplasms2
Autoimmune Diseases1
Chronic Kidney Disease-Mineral and Bone Disorder1
Female Urogenital Diseases1
Female Urogenital Diseases and Pregnancy Complications1
Glomerulonephritis1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.